Zivcić-Cosić Stela, Fućak Marina, Orlić Petar, Vujaklija-Stipanović Ksenija, Orlić Lidija, Racki Sanjin, Grzetic Mirjana, Matić-Glazar Durdica, Zelić Miomir, Mavrić Zarko
Klinika za internu medicinu, Klinicki bolnicki centar Rijeka, Medicinski fakultet u Rijeci, Rijeka, Hrvatska.
Acta Med Croatica. 2003;57(1):65-8.
On December 31, 2001, 2486 patients with terminal renal failure received dialysis treatment in Croatia. Only one third of the patients are registered on the national waiting list for cadaveric kidney transplant. In most of the others, transplantation is impossible because of comorbidity. This is mainly due to the steadily growing age of the dialytic population and therefore a higher incidence of cardiovascular disease and diabetes. Still, evaluation of the potential recipients of cadaveric kidney transplant, registered on the waiting list, often reveals contraindications for transplantation. The aim of this study was to determine the incidence and type of contraindications in transplant candidates, found during immediate preoperative evaluation. Analysis of these data should help in determining how contraindications can be early detected and prevented. Before registering onto the national waiting list transplant candidates need to be thoroughly investigated including detailed history, physical examination, routine diagnostic procedures and additional examinations, if needed, to exclude or evaluate the possibly existing contraindications for transplantation. During the period from January 1997 until June 2002, 145 potential recipients from the national waiting list were referred to the Rijeka University Hospital Center and evaluated for kidney transplantation. Eighty-eight patients underwent transplantation. Preoperative evaluation revealed contraindications for transplantation in 52 (35.9%) candidates. Twenty-two (15.2%) patients had a positive cross-match with donor lymphocytes, 6 (4.1%) patients refused transplantation, and in 24 (16.6%) patients serious comorbidity was the reason for not being accepted for transplantation and for their withdrawal from the national waiting list. Comorbidity was mainly due to cardiovascular disease (12 patients--8.3%) and infection (8 patients--5.5%). These data show a high incidence of contraindications found during the immediate preoperative evaluation of potential kidney recipients. It was the case in more than one third of patients. During the evaluation of potential candidates for kidney transplantation special attention should be addressed to the presence of cardiovascular morbidity and infection. Peripheral vascular occlusive disease, cardiac status and/or cerebrovascular disease should be evaluated. Measures used to treat or reduce the development of complications include an optimal control of blood pressure, serum phosphate, hyperparathyroidism, dyslipidemia, and renal anemia. The sites of infection must be treated and eradicated, because immunosuppressive treatment is a threat to the transplant recipient's life. The second most common cause of refusal of potential candidates was a positive cross-match with donor lymphocytes. Sensitization to human leukocyte antigens can be prevented by the avoiding of blood transfusions and use of erythopoietin in treating renal anemia. To minimize the morbidity and mortality, the potential kidney recipients should undergo rigorous selection and thorough evaluation before including them into the waiting list for kidney transplantation. Afterwards, regular examinations are obligatory to reveal contraindications, proceed to medical interventions and treat concomitant diseases in time, which can influence the patient's survival. In case that contraindications for transplantation arise, the patient must be temporarily or definitely removed from the waiting list.
2001年12月31日,克罗地亚有2486例终末期肾衰竭患者接受透析治疗。只有三分之一的患者登记在全国尸体肾移植等待名单上。在其他大多数患者中,由于合并症而无法进行移植。这主要是由于透析人群的年龄不断增长,因此心血管疾病和糖尿病的发病率更高。尽管如此,对登记在等待名单上的尸体肾移植潜在受者进行评估时,仍常常发现移植存在禁忌证。本研究的目的是确定在术前即刻评估中发现的移植候选者禁忌证的发生率和类型。对这些数据进行分析应有助于确定如何早期发现并预防禁忌证。在登记进入全国等待名单之前,移植候选者需要进行全面检查,包括详细的病史、体格检查、常规诊断程序以及必要时的额外检查,以排除或评估可能存在的移植禁忌证。在1997年1月至2002年6月期间,145名来自全国等待名单的潜在受者被转诊至里耶卡大学医院中心并接受肾移植评估。88例患者接受了移植。术前评估发现52例(35.9%)候选者存在移植禁忌证。22例(15.2%)患者与供体淋巴细胞交叉配型呈阳性,6例(4.1%)患者拒绝移植,24例(16.6%)患者因严重合并症而未被接受移植并退出全国等待名单。合并症主要归因于心血管疾病(12例患者,占8.3%)和感染(8例患者,占5.5%)。这些数据表明,在对潜在肾受者进行术前即刻评估时,禁忌证的发生率很高。超过三分之一的患者存在这种情况。在评估肾移植潜在候选者时,应特别关注心血管疾病和感染的存在。应评估外周血管闭塞性疾病、心脏状况和/或脑血管疾病。用于治疗或减少并发症发生的措施包括最佳控制血压、血清磷酸盐、甲状旁腺功能亢进、血脂异常和肾性贫血。必须治疗并根除感染部位,因为免疫抑制治疗对移植受者的生命构成威胁。潜在候选者拒绝移植的第二常见原因是与供体淋巴细胞交叉配型呈阳性。通过避免输血和使用促红细胞生成素治疗肾性贫血,可以预防对人类白细胞抗原的致敏。为了将发病率和死亡率降至最低,在将潜在肾受者纳入肾移植等待名单之前,应进行严格的筛选和全面的评估。之后,定期检查是必不可少的,以便发现禁忌证、及时进行医疗干预并治疗伴发疾病,这些都可能影响患者的生存。如果出现移植禁忌证,患者必须暂时或永久从等待名单中移除。